123 related articles for article (PubMed ID: 6417727)
1. Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).
Sun FF; McGuire JC
Prostaglandins; 1983 Aug; 26(2):211-21. PubMed ID: 6417727
[TBL] [Abstract][Full Text] [Related]
2. Ionophore-dependent generation of eicosanoids in human dispersed lung cells. Modulation by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60,257).
Robinson C; Holgate ST
Biochem Pharmacol; 1986 Jun; 35(11):1903-8. PubMed ID: 3087365
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
Ozaki Y; Ohashi T; Niwa Y
Biochem Pharmacol; 1986 Oct; 35(20):3481-8. PubMed ID: 3021173
[TBL] [Abstract][Full Text] [Related]
4. 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies.
Bach MK; Brashler JR; Smith HW; Fitzpatrick FA; Sun FF; McGuire JC
Prostaglandins; 1982 May; 23(5):759-71. PubMed ID: 6812165
[TBL] [Abstract][Full Text] [Related]
5. Effect of the 5-lipoxygenase inhibitor piriprost on superoxide production by human neutrophils.
Flament J; Schandene L; Boeynaems JM
Prostaglandins Leukot Essent Fatty Acids; 1988 Dec; 34(3):175-80. PubMed ID: 2851839
[TBL] [Abstract][Full Text] [Related]
6. The synthesis of 6,9-deepoxy-6,9-N-phenylimino-delta 6,8-prostaglandin I1. A novel inhibitor of leukotriene C and D synthesis.
Smith HW; Bach MK; Harrison AW; Johnson HG; Major NJ; Wasserman MA
Prostaglandins; 1982 Oct; 24(4):543-6. PubMed ID: 6817384
[TBL] [Abstract][Full Text] [Related]
7. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
Graff G; Anderson LA
Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor.
Bach MK; Brashler JR
Biochem Pharmacol; 1986 Feb; 35(3):425-33. PubMed ID: 3004501
[TBL] [Abstract][Full Text] [Related]
9. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
Dahl ML; Puustinen T; Uotila P
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
[TBL] [Abstract][Full Text] [Related]
10. Effect of Piriprost, a 5-lipoxygenase inhibitor, on leukocyte accumulation during thioglycollate-induced acute inflammation.
Lawson CF; Smith HW; Fitzpatrick FA
Wien Klin Wochenschr; 1986 Feb; 98(4):110-3. PubMed ID: 3085355
[TBL] [Abstract][Full Text] [Related]
11. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
Marcus AJ; Broekman MJ; Safier LB; Ullman HL; Islam N; Serhan CN; Weissmann G
Clin Physiol Biochem; 1984; 2(2-3):78-83. PubMed ID: 6435929
[TBL] [Abstract][Full Text] [Related]
12. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
13. Preferential inhibition of 5-lipoxygenase activity by manoalide.
De Vries GW; Amdahl L; Mobasser A; Wenzel M; Wheeler LA
Biochem Pharmacol; 1988 Aug; 37(15):2899-905. PubMed ID: 2840081
[TBL] [Abstract][Full Text] [Related]
14. 6,7,4'-Trihydroxyisoflavan: a potent and selective inhibitor of 5-lipoxygenase in human and porcine peripheral blood leukocytes.
Kuhl P; Shiloh R; Jha H; Murawski U; Zilliken F
Prostaglandins; 1984 Dec; 28(6):783-804. PubMed ID: 6441190
[TBL] [Abstract][Full Text] [Related]
15. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of leukotriene C4 and B4 generation by human eosinophils and neutrophils with the lipoxygenase pathway inhibitors U60257 and BW755C.
Cromwell O; Shaw RJ; Walsh GM; Mallet AI; Kay AB
Int J Immunopharmacol; 1985; 7(5):775-81. PubMed ID: 2995265
[TBL] [Abstract][Full Text] [Related]
17. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
Hopkins NK; Schaub RG; Gorman RR
Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human neutrophil 5-lipoxygenase by exogenous arachidonic acid: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins.
McColl SR; Krump E; Naccache PH; Caon AC; Borgeat P
Br J Pharmacol; 1989 Aug; 97(4):1265-73. PubMed ID: 2507084
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
20. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
Schulz R; Seeger W
Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
